Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration
Mladen V. Tzvetkov, Joao N.S. Pereira, Ingolf Meineke, et al.
Biochemical Pharmacology (2013) Vol. 86, Iss. 5, pp. 666-678
Open Access | Times Cited: 190

Showing 1-25 of 190 citing articles:

Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study
Tanja Dujić, Kaixin Zhou, Louise A. Donnelly, et al.
Diabetes (2014) Vol. 64, Iss. 5, pp. 1786-1793
Open Access | Times Cited: 240
Organic Cation Transporters in Health and Disease
Hermann Koepsell
Pharmacological Reviews (2019) Vol. 72, Iss. 1, pp. 253-319
Open Access | Times Cited: 235
SLC Family Transporters
Xiaodong Liu
Advances in experimental medicine and biology (2019), pp. 101-202
Closed Access | Times Cited: 196
Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium
Sook Wah Yee, Deanna J. Brackman, E Ennis, et al.
Clinical Pharmacology & Therapeutics (2018) Vol. 104, Iss. 5, pp. 803-817
Open Access | Times Cited: 117
The genetic landscape of the human solute carrier (SLC) transporter superfamily
L.C. Schaller, Volker M. Lauschke
Human Genetics (2019) Vol. 138, Iss. 11-12, pp. 1359-1377
Open Access | Times Cited: 106
Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1
Tina Seitz, Robert Stalmann, Nawar Dalila, et al.
Genome Medicine (2015) Vol. 7, Iss. 1
Open Access | Times Cited: 98
Expression, regulation and function of intestinal drug transporters: an update
Janett Müller, Markus Keiser, Marek Droździk, et al.
Biological Chemistry (2016) Vol. 398, Iss. 2, pp. 175-192
Closed Access | Times Cited: 95
Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2
Yang Suo, Nicholas J. Wright, Hugo Guterres, et al.
Nature Structural & Molecular Biology (2023) Vol. 30, Iss. 7, pp. 1001-1011
Closed Access | Times Cited: 37
Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance
John O. Miners, Thomas M. Polasek, Julie-Ann Hulin, et al.
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108459-108459
Closed Access | Times Cited: 28
The full spectrum of SLC22 OCT1 mutations illuminates the bridge between drug transporter biophysics and pharmacogenomics
Sook Wah Yee, Christian B. Macdonald, Darko Mitrovic, et al.
Molecular Cell (2024) Vol. 84, Iss. 10, pp. 1932-1947.e10
Closed Access | Times Cited: 13
Structural insights into human organic cation transporter 1 transport and inhibition
Shuhao Zhang, Angqi Zhu, Fang Kong, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
The Poorly Membrane Permeable Antipsychotic Drugs Amisulpride and Sulpiride Are Substrates of the Organic Cation Transporters from the SLC22 Family
Joao N.S. Pereira, Sina Tadjerpisheh, Manar Abu Abed, et al.
The AAPS Journal (2014) Vol. 16, Iss. 6, pp. 1247-1258
Open Access | Times Cited: 91
OCT1 Genetic Variants Influence the Pharmacokinetics of Morphine in Children
Tsuyoshi Fukuda, Vidya Chidambaran, Tomoyuki Mizuno, et al.
Pharmacogenomics (2013) Vol. 14, Iss. 10, pp. 1141-1151
Open Access | Times Cited: 88
OCT1 mediates hepatic uptake of sumatriptan and loss‐of‐function OCT1 polymorphisms affect sumatriptan pharmacokinetics
Johannes Matthaei, David Kuron, Frank Faltraco, et al.
Clinical Pharmacology & Therapeutics (2015) Vol. 99, Iss. 6, pp. 633-641
Closed Access | Times Cited: 87
Role of organic cation transporters in drug–drug interaction
Hermann Koepsell
Expert Opinion on Drug Metabolism & Toxicology (2015) Vol. 11, Iss. 10, pp. 1619-1633
Closed Access | Times Cited: 85
Endogenous opiates and behavior: 2014
Richard J. Bodnar
Peptides (2015) Vol. 75, pp. 18-70
Closed Access | Times Cited: 79
A Comprehensive Review of Drug–Drug Interactions with Metformin
Tore Bjerregaard Stage, Kim Brøsen, Mette Marie Hougaard Christensen
Clinical Pharmacokinetics (2015) Vol. 54, Iss. 8, pp. 811-824
Closed Access | Times Cited: 78
Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis
BC Ferslew, CK Johnston, Eleftheria Tsakalozou, et al.
Clinical Pharmacology & Therapeutics (2015) Vol. 97, Iss. 4, pp. 419-427
Open Access | Times Cited: 76
ABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children
Raja Venkatasubramanian, Tsuyoshi Fukuda, Jing Niu, et al.
Pharmacogenomics (2014) Vol. 15, Iss. 10, pp. 1297-1309
Open Access | Times Cited: 73
DARK Classics in Chemical Neuroscience: Morphine
Andrea L. Devereaux, Susan L. Mercer, Christopher W. Cunningham
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 10, pp. 2395-2407
Closed Access | Times Cited: 73
The role of drug transporters in the kidney: lessons from tenofovir
Darren Moss, Megan Neary, Andrew Owen
Frontiers in Pharmacology (2014) Vol. 5
Open Access | Times Cited: 69
Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition
Fanfan Zhou, Ling Zhu, Ke Wang, et al.
Advanced Drug Delivery Reviews (2016) Vol. 116, pp. 21-36
Closed Access | Times Cited: 69
Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: “SLC-Phenotyping” Using Primary Human Hepatocytes
Yi‐An Bi, Chester Costales, Sumathy Mathialagan, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 370, Iss. 1, pp. 72-83
Open Access | Times Cited: 69
In Situ Perfusion Model in Rat Colon for Drug Absorption Studies: Comparison with Small Intestine and Caco-2 Cell Model
Isabel Lozoya-Agulló, Isabel González‐Álvarez, Marta González‐Álvarez, et al.
Journal of Pharmaceutical Sciences (2015) Vol. 104, Iss. 9, pp. 3136-3145
Open Access | Times Cited: 65
Quantitative Proteomics and Mechanistic Modeling of Transporter‐Mediated Disposition in Nonalcoholic Fatty Liver Disease
Anna Vildhede, Emi Kimoto, Ryan M. Pelis, et al.
Clinical Pharmacology & Therapeutics (2019) Vol. 107, Iss. 5, pp. 1128-1137
Closed Access | Times Cited: 64
Page 1 - Next Page

Scroll to top